{
    "nctId": "NCT03953326",
    "briefTitle": "HeartPhone Cancer Survivors Trial 2019",
    "officialTitle": "Digital Intervention to Promote Physical Activity and Improve Cardiovascular Health Among Cancer Survivors",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Leukemia, Lymphoma",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 3,
    "primaryOutcomeMeasure": "Physical activity volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18-65 years\n* Diagnosis of breast cancer, leukemia, or lymphoma \\<15 yrs\n* Completed chemotherapy with cardiotoxic anthracycline-based agents 1+ year ago\n* English-proficiency\n* Own \\& use smartphone with Android operating system\n\nMain Study and Ancillary Study Exclusion Criteria:\n\n* Currently receiving curative treatment for cancer\n* 90+ min/week moderate (or greater) intensity PA\n* Any medical contraindications on the Physical Activity Readiness Questionnaire\n* Require an assistive device for mobility or has any other condition that may limit or prevent participation in moderate-intensity physical activity\n* Current smoker\n* Pregnant or planning to become pregnant in the next 6 mos/breastfeeding\n* Allergy to test substances\n* Allergy to latex\n\nAncillary Study:\n\n* Taking metformin\n* Current medications that could conceivably alter the cardiovascular or thermoregulatory control or responses (e.g. beta blockers, calcium channel blockers, angiotensin receptor blockers)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}